1. DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease. (25th January 2019) Authors: Verstockt, B; Sudahakar, P; Creyns, B; Verstockt, S; Cremer, J; Wollants, W-J; Organe, S; Korcsmaros, T; Madgwick, M; Van Assche, G; Breynaert, C; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Issue 4 (27th June 2011) Authors: Márquez, L; Shen, C; Cleynen, I; De Hertogh, G; Van Steen, K; Machiels, K; Perrier, C; Ballet, V; Organe, S; Ferrante, M; Henckaerts, L; Galicia, G; Rutgeerts, P; Ceuppens, J L; Vermeire, S Journal: Gut Issue: Volume 61:Issue 4(2012) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗